379 related articles for article (PubMed ID: 26999597)
1. Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis.
Ceotto-Vigoder H; Marques SL; Santos IN; Alves MD; Barrias ES; Potter A; Alviano DS; Bastos MC
J Appl Microbiol; 2016 Jul; 121(1):101-14. PubMed ID: 26999597
[TBL] [Abstract][Full Text] [Related]
2. Chimeric phage lysins act synergistically with lysostaphin to kill mastitis-causing Staphylococcus aureus in murine mammary glands.
Schmelcher M; Powell AM; Becker SC; Camp MJ; Donovan DM
Appl Environ Microbiol; 2012 Apr; 78(7):2297-305. PubMed ID: 22286996
[TBL] [Abstract][Full Text] [Related]
3. Nisin penetration and efficacy against Staphylococcus aureus biofilms under continuous-flow conditions.
Godoy-Santos F; Pitts B; Stewart PS; Mantovani HC
Microbiology (Reading); 2019 Jul; 165(7):761-771. PubMed ID: 31088602
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic resistance in Staphylococcus aureus strains isolated from cows with mastitis in eastern Poland and analysis of susceptibility of resistant strains to alternative nonantibiotic agents: lysostaphin, nisin and polymyxin B.
Szweda P; Schielmann M; Frankowska A; Kot B; Zalewska M
J Vet Med Sci; 2014 Mar; 76(3):355-62. PubMed ID: 24212507
[TBL] [Abstract][Full Text] [Related]
5. Vancomycin and nisin A are effective against biofilms of multi-drug resistant Staphylococcus aureus isolates from human milk.
Angelopoulou A; Field D; Pérez-Ibarreche M; Warda AK; Hill C; Ross RP
PLoS One; 2020; 15(5):e0233284. PubMed ID: 32469943
[TBL] [Abstract][Full Text] [Related]
6. Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture.
Melchior MB; Fink-Gremmels J; Gaastra W
J Vet Med B Infect Dis Vet Public Health; 2006 Sep; 53(7):326-32. PubMed ID: 16930277
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a lysostaphin-fusion protein as a dry-cow therapy for Staphylococcus aureus mastitis in dairy cattle.
Hoernig KJ; Donovan DM; Pithua P; Williams F; Middleton JR
J Dairy Sci; 2016 Jun; 99(6):4638-4646. PubMed ID: 27040789
[TBL] [Abstract][Full Text] [Related]
8. Extended biofilm susceptibility assay for Staphylococcus aureus bovine mastitis isolates: evidence for association between genetic makeup and biofilm susceptibility.
Melchior MB; van Osch MH; Lam TJ; Vernooij JC; Gaastra W; Fink-Gremmels J
J Dairy Sci; 2011 Dec; 94(12):5926-37. PubMed ID: 22118083
[TBL] [Abstract][Full Text] [Related]
9. Effects of lysostaphin on Staphylococcus aureus infections of the mouse mammary gland.
Bramley AJ; Foster R
Res Vet Sci; 1990 Jul; 49(1):120-1. PubMed ID: 2382049
[TBL] [Abstract][Full Text] [Related]
10. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic.
Oldham ER; Daley MJ
J Dairy Sci; 1991 Dec; 74(12):4175-82. PubMed ID: 1787188
[TBL] [Abstract][Full Text] [Related]
11. The effect of nisin on the biofilm production, antimicrobial susceptibility and biofilm formation of Staphylococcus aureus and Pseudomonas aeruginosa.
Ghapanvari P; Taheri M; Jalilian FA; Dehbashi S; Dezfuli AAZ; Arabestani MR
Eur J Med Res; 2022 Sep; 27(1):173. PubMed ID: 36076252
[TBL] [Abstract][Full Text] [Related]
12. Combination antimicrobial therapy: in vitro synergistic effect of anti-staphylococcal drug oxacillin with antimicrobial peptide nisin against Staphylococcus epidermidis clinical isolates and Staphylococcus aureus biofilms.
Sharafi T; Ghaemi EA; Rafiee M; Ardebili A
Ann Clin Microbiol Antimicrob; 2024 Jan; 23(1):7. PubMed ID: 38245727
[TBL] [Abstract][Full Text] [Related]
13. Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilms.
Melchior MB; Fink-Gremmels J; Gaastra W
Vet Microbiol; 2007 Nov; 125(1-2):141-9. PubMed ID: 17600640
[TBL] [Abstract][Full Text] [Related]
14. Investigation of the antibiotic resistance and biofilm-forming ability of Staphylococcus aureus from subclinical bovine mastitis cases.
Aslantaş Ö; Demir C
J Dairy Sci; 2016 Nov; 99(11):8607-8613. PubMed ID: 27592437
[TBL] [Abstract][Full Text] [Related]
15. Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication.
Walencka E; Sadowska B; Rozalska S; Hryniewicz W; Rózalska B
Pol J Microbiol; 2005; 54(3):191-200. PubMed ID: 16450834
[TBL] [Abstract][Full Text] [Related]
16.
Shukla SK; Rao TS
Indian J Med Res; 2017 Jul; 146(Supplement):S1-S8. PubMed ID: 29205189
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of nisin in treatment of clinical mastitis in lactating dairy cows.
Cao LT; Wu JQ; Xie F; Hu SH; Mo Y
J Dairy Sci; 2007 Aug; 90(8):3980-5. PubMed ID: 17639009
[TBL] [Abstract][Full Text] [Related]
18. Effects of nisin and lysozyme on growth inhibition and biofilm formation capacity of Staphylococcus aureus strains isolated from raw milk and cheese samples.
Sudagidan M; Yemenicioğlu A
J Food Prot; 2012 Sep; 75(9):1627-33. PubMed ID: 22947470
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and/or lysostaphin.
Walencka E; Sadowska B; Rózalska S; Hryniewicz W; Rózalska B
Folia Microbiol (Praha); 2006; 51(5):381-6. PubMed ID: 17176756
[TBL] [Abstract][Full Text] [Related]
20. Changes in the composition and architecture of staphylococcal biofilm by nisin.
Andre C; de Jesus Pimentel-Filho N; de Almeida Costa PM; Vanetti MCD
Braz J Microbiol; 2019 Oct; 50(4):1083-1090. PubMed ID: 31456169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
